Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
Domain	Ribosomal_L26	RPL26 RPL26L1	2.61e-05	2	96	2	PF16906
Domain	Ribosomal_L26/L24P_euk/arc	RPL26 RPL26L1	2.61e-05	2	96	2	IPR005756
Domain	Ribosomal_L24/26_CS	RPL26 RPL26L1	7.82e-05	3	96	2	IPR005825
Domain	RIBOSOMAL_L24	RPL26 RPL26L1	7.82e-05	3	96	2	PS01108
Pubmed	Organization and evolutionary relatedness of OR37 olfactory receptor genes in mouse and human.	OR13C5 OR2S2 OR13C9 OR13C2 OR13C7	1.46e-10	12	101	5	12906860
Pubmed	Exploring the link between MORF4L1 and risk of breast cancer.	KPNA5 ATR BRCA2 NFKB1	6.81e-07	24	101	4	21466675
Pubmed	ATAC and SAGA co-activator complexes utilize co-translational assembly, but their cellular localization properties and functions are distinct.	SUPT20H POLR2I YEATS2 TADA2A	8.32e-06	44	101	4	37682711
Pubmed	TRE17/USP6 oncogene translocated in aneurysmal bone cyst induces matrix metalloproteinase production via activation of NF-kappaB.	USP6 NFKB1	8.35e-06	2	101	2	20418905
Pubmed	DNA-dependent activator of IFN-regulatory factors enhances the transcription of HIV-1 through NF-κB.	ZBP1 NFKB1	8.35e-06	2	101	2	20599623
Pubmed	Evidence for inflammatory signaling in idiopathic pulmonary artery hypertension: TRPC6 and nuclear factor-kappaB.	TRPC6 NFKB1	8.35e-06	2	101	2	19414653
Pubmed	A functional single-nucleotide polymorphism in the TRPC6 gene promoter associated with idiopathic pulmonary arterial hypertension.	TRPC6 NFKB1	8.35e-06	2	101	2	19380626
Pubmed	HIV latency.	POLR2I POLR2M NFKB1	1.05e-05	15	101	3	22229121
Pubmed	Elucidation of the Fanconi Anemia Protein Network in Meiosis and Its Function in the Regulation of Histone Modifications.	ATR FANCB BRCA2	1.30e-05	16	101	3	27760317
Pubmed	Crosstalk between SUMOylation and ubiquitylation controls DNA end resection by maintaining MRE11 homeostasis on chromatin.	SENP3 PIAS1	2.50e-05	3	101	2	36050397
Pubmed	GRK2 protein-mediated transphosphorylation contributes to loss of function of μ-opioid receptors induced by neuropeptide FF (NPFF2) receptors.	NPFFR2 GRK2	2.50e-05	3	101	2	22375000
Pubmed	TRPC6 up-regulation in Ang II-induced podocyte apoptosis might result from ERK activation and NF-kappaB translocation.	TRPC6 NFKB1	2.50e-05	3	101	2	19546355
Pubmed	The mTORC2/Akt/NFκB Pathway-Mediated Activation of TRPC6 Participates in Adriamycin-Induced Podocyte Apoptosis.	TRPC6 NFKB1	2.50e-05	3	101	2	27960162
Pubmed	Transient receptor potential channel 6 regulates abnormal cardiac S-nitrosylation in Duchenne muscular dystrophy.	TRPC6 UTRN	2.50e-05	3	101	2	29187535
Pubmed	Nedd8-activating enzyme inhibitor MLN4924 provides synergy with mitomycin C through interactions with ATR, BRCA1/BRCA2, and chromatin dynamics pathways.	ATR BRCA2	2.50e-05	3	101	2	24672057
Pubmed	Pharmacological TRPC6 inhibition improves survival and muscle function in mice with Duchenne muscular dystrophy.	TRPC6 UTRN	2.50e-05	3	101	2	36099033
Pubmed	Myeloid-specific GPCR kinase-2 negatively regulates NF-κB1p105-ERK pathway and limits endotoxemic shock in mice.	GRK2 NFKB1	2.50e-05	3	101	2	20717897
Pubmed	Leucine-rich repeat kinase 2 associates with lipid rafts.	LRRK2 AP1G1	2.50e-05	3	101	2	17341485
Pubmed	Proximity-dependent biotin identification (BioID) reveals a dynamic LSD1-CoREST interactome during embryonic stem cell differentiation.	ZDBF2 YEATS2 TBC1D4 BRCA2 TADA2A PC UTRN NXF1	3.11e-05	418	101	8	34709266
Pubmed	CATACOMB: An endogenous inducible gene that antagonizes H3K27 methylation activity of Polycomb repressive complex 2 via an H3K27M-like mechanism.	EPC2 JARID2 AEBP2	4.04e-05	23	101	3	31281901
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	RPL26 WWP2 PARP8 FSIP2 TBC1D4 FAM13A MTUS1 PC UTRN CEP170B AQR	4.21e-05	861	101	11	36931259
Pubmed	Interaction between BRCA1/BRCA2 and ATM/ATR associate with breast cancer susceptibility in a Chinese Han population.	ATR BRCA2	4.99e-05	4	101	2	20513533
Pubmed	Basal NF-κB controls IL-7 responsiveness of quiescent naïve T cells.	NFKB1 IL7R	4.99e-05	4	101	2	24799710
Pubmed	Clustering of Genetic Anomalies of Cilia Outer Dynein Arm and Central Apparatus in Patients with Transposition of the Great Arteries.	ODAD4 HYDIN	4.99e-05	4	101	2	36140829
Pubmed	Arginine methylation of STAT1 regulates its dephosphorylation by T cell protein tyrosine phosphatase.	PIAS1 PTPN2	4.99e-05	4	101	2	12171910
Pubmed	ATR inhibition broadly sensitizes ovarian cancer cells to chemotherapy independent of BRCA status.	ATR BRCA2	4.99e-05	4	101	2	23548269
Pubmed	Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability.	SUPT20H ZDBF2 PIAS1 YEATS2 TBC1D4 BRCA2 SLFN11 CEP170B NXF1	5.58e-05	588	101	9	38580884
Pubmed	Human ATAC Is a GCN5/PCAF-containing acetylase complex with a novel NC2-like histone fold module that interacts with the TATA-binding protein.	SUPT20H YEATS2 TADA2A	6.61e-05	27	101	3	18838386
Pubmed	Promoter methylation patterns of ATM, ATR, BRCA1, BRCA2 and p53 as putative cancer risk modifiers in Jewish BRCA1/BRCA2 mutation carriers.	ATR BRCA2	8.30e-05	5	101	2	18642075
Pubmed	Hyperactive adverse mechanical stress responses in dystrophic heart are coupled to transient receptor potential canonical 6 and blocked by cGMP-protein kinase G modulation.	TRPC6 UTRN	8.30e-05	5	101	2	24449818
Pubmed	JARID2 and AEBP2 regulate PRC2 in the presence of H2AK119ub1 and other histone modifications.	JARID2 AEBP2	8.30e-05	5	101	2	33479123
Pubmed	Splicing variations in the ligand-binding domain of ApoER2 results in functional differences in the binding properties to Reelin.	ITPR1 LRP8	8.30e-05	5	101	2	19167437
Pubmed	G-protein-coupled-receptor kinases mediate TNFα-induced NFκB signalling via direct interaction with and phosphorylation of IκBα.	GRK2 NFKB1	8.30e-05	5	101	2	19796012
Pubmed	Temporal patterning of apical progenitors and their daughter neurons in the developing neocortex.	WNT7B ITPR1 LRP8 LRRN3	9.85e-05	82	101	4	31073041
Pubmed	Identifications of novel host cell factors that interact with the receptor-binding domain of the SARS-CoV-2 spike protein.	ATR SENP3 PATL1 PIAS1 ITPR1 AP1G1 NXF1 PLXNB1 AQR	1.19e-04	650	101	9	38777146
Pubmed	Systematic mapping of genetic interactions for de novo fatty acid synthesis identifies C12orf49 as a regulator of lipid metabolism.	EPC2 SUPT20H ZDBF2 PATL1 GTPBP10 PIAS1 FAM169A AEBP2 SLFN11 TADA2A MAGEB17 PC NXF1	1.24e-04	1327	101	13	32694731
Pubmed	ATR/Chk1 signaling induces autophagy through sumoylated RhoB-mediated lysosomal translocation of TSC2 after DNA damage.	ATR PIAS1	1.24e-04	6	101	2	30297842
Pubmed	IL-7/IL-7 receptor axis stimulates prostate cancer cell invasion and migration via AKT/NF-κB pathway.	NFKB1 IL7R	1.24e-04	6	101	2	27611862
Pubmed	Jarid2/Jumonji coordinates control of PRC2 enzymatic activity and target gene occupancy in pluripotent cells.	JARID2 AEBP2	1.24e-04	6	101	2	20064375
Pubmed	Identification and developmental analysis of genes expressed by dopaminergic neurons of the substantia nigra pars compacta.	ZDBF2 PATL1 JARID2 USP6	1.41e-04	90	101	4	15033168
Pubmed	Identification and functional characterization of transcriptional activators in human cells.	EPC2 SUPT20H MED15 YEATS2 AEBP2 SLFN11 NXF1	1.67e-04	398	101	7	35016035
Pubmed	Global mapping of herpesvirus-host protein complexes reveals a transcription strategy for late genes.	KPNA5 WWP2 SENP3 POLR2I POLR2M GTPBP10 PPP1R7 YEATS2	1.68e-04	533	101	8	25544563
Pubmed	An acetylation/deacetylation-SUMOylation switch through a phylogenetically conserved psiKXEP motif in the tumor suppressor HIC1 regulates transcriptional repression activity.	SENP3 PIAS1	1.74e-04	7	101	2	17283066
Pubmed	Activation of PPAR-alpha in streptozotocin-induced diabetes is essential for resistance against acetaminophen toxicity.	CYP1A2 NFKB1	1.74e-04	7	101	2	12958197
Pubmed	Jarid2 and PRC2, partners in regulating gene expression.	JARID2 AEBP2	1.74e-04	7	101	2	20123894
Pubmed	Global analysis of host-pathogen interactions that regulate early-stage HIV-1 replication.	POLR2I MED15 GRK2 AEBP2 NXF1 AQR	1.83e-04	283	101	6	18854154
Pubmed	The cell proliferation antigen Ki-67 organises heterochromatin.	EPC2 ATR SENP3 AP1G1 RPL26L1 UTRN NXF1	2.00e-04	410	101	7	26949251
Pubmed	SETDB1 Links the Meiotic DNA Damage Response to Sex Chromosome Silencing in Mice.	ATR BRCA2	2.31e-04	8	101	2	30393076
Pubmed	Nef and TNFalpha are coplayers that favor HIV-1 replication in monocytic cells and primary macrophages.	AP1G1 NFKB1	2.31e-04	8	101	2	18336259
Pubmed	L-arginine decreases inflammation and modulates the nuclear factor-kappaB/matrix metalloproteinase cascade in mdx muscle fibers.	NFKB1 UTRN	2.31e-04	8	101	2	18458097
Pubmed	Phenotypic and Interaction Profiling of the Human Phosphatases Identifies Diverse Mitotic Regulators.	ZNF280C TULP3 ITPR1 PPP1R7 PTPN2 TBC1D4 MTUS1 NFKB1 SLFN11 PC UTRN	2.39e-04	1049	101	11	27880917
Pubmed	The interaction of Piasy with Trim32, an E3-ubiquitin ligase mutated in limb-girdle muscular dystrophy type 2H, promotes Piasy degradation and regulates UVB-induced keratinocyte apoptosis through NFkappaB.	PIAS1 NFKB1	2.97e-04	9	101	2	16816390
Pubmed	Homer binds TRPC family channels and is required for gating of TRPC1 by IP3 receptors.	TRPC6 ITPR1	2.97e-04	9	101	2	14505576
Pubmed	Small subfamily of olfactory receptor genes: structural features, expression pattern and genomic organization.	OR2S2 OR13C7	2.97e-04	9	101	2	10452948
Pubmed	Apical localization of a functional TRPC3/TRPC6-Ca2+-signaling complex in polarized epithelial cells. Role in apical Ca2+ influx.	TRPC6 ITPR1	2.97e-04	9	101	2	15623527
Pubmed	JARID2 regulates binding of the Polycomb repressive complex 2 to target genes in ES cells.	JARID2 AEBP2	2.97e-04	9	101	2	20075857
Pubmed	RelB is required for Peyer's patch development: differential regulation of p52-RelB by lymphotoxin and TNF.	NFKB1 IL7R	2.97e-04	9	101	2	12505990
Pubmed	LAS1L interacts with the mammalian Rix1 complex to regulate ribosome biogenesis.	RPL26 SENP3	2.97e-04	9	101	2	22190735
Pubmed	PIAS1 and STAT-3 impair the tumoricidal potential of IFN-γ-stimulated mouse dendritic cells generated with IL-15.	PIAS1 NFKB1	2.97e-04	9	101	2	24777831
Pubmed	Mapping the mammalian ribosome quality control complex interactome using proximity labeling approaches.	POLR2I MED15 SEC24D AP1G1 PC	3.17e-04	202	101	5	29540532
Pubmed	A set of consensus mammalian mediator subunits identified by multidimensional protein identification technology.	POLR2I POLR2M MED15	3.51e-04	47	101	3	15175163
Pubmed	Physiological significance of proteolytic processing of Reelin revealed by cleavage-resistant Reelin knock-in mice.	ITPR1 LRP8	3.70e-04	10	101	2	32161359
Pubmed	EZHIP constrains Polycomb Repressive Complex 2 activity in germ cells.	JARID2 AEBP2	3.70e-04	10	101	2	31451685
Pubmed	FGF8 can activate Gbx2 and transform regions of the rostral mouse brain into a hindbrain fate.	WNT7B IL7R	3.70e-04	10	101	2	10518499
Pubmed	Exome sequencing identifies breast cancer susceptibility genes and defines the contribution of coding variants to breast cancer risk.	ATR BRCA2	3.70e-04	10	101	2	37592023
Pubmed	Interactomes of Glycogen Synthase Kinase-3 Isoforms.	ZDBF2 TBC1D4 MTUS1 UTRN CEP170B	3.71e-04	209	101	5	36779422
Pubmed	The RNA-mediated estrogen receptor α interactome of hormone-dependent human breast cancer cell nuclei.	SUPT20H CLK4 SENP3 POLR2I GTPBP10 PIAS1 MED15 JARID2 AP1G1 UTRN CEP170B NXF1 AQR	3.98e-04	1497	101	13	31527615
Pubmed	A protein-protein interaction network for human inherited ataxias and disorders of Purkinje cell degeneration.	KPNA5 SUPT20H WWP2 TDRD7 MED15 USP6 SUGP2 NXF1	4.05e-04	608	101	8	16713569
Pubmed	Polycomb-like 3 promotes polycomb repressive complex 2 binding to CpG islands and embryonic stem cell self-renewal.	JARID2 AEBP2	4.51e-04	11	101	2	22438827
Pubmed	Genome-wide association study identifies TNFSF15 and POU2AF1 as susceptibility loci for primary biliary cirrhosis in the Japanese population.	NFKB1 IL7R	4.51e-04	11	101	2	23000144
Pubmed	The metazoan ATAC and SAGA coactivator HAT complexes regulate different sets of inducible target genes.	YEATS2 TADA2A	4.51e-04	11	101	2	19936620
Pubmed	TOPORS-mediated RAD51 SUMOylation facilitates homologous recombination repair.	PIAS1 BRCA2	4.51e-04	11	101	2	35061896
Pubmed	SAGA and ATAC histone acetyl transferase complexes regulate distinct sets of genes and ATAC defines a class of p300-independent enhancers.	YEATS2 TADA2A	4.51e-04	11	101	2	22055187
Pubmed	MYC Protein Interactome Profiling Reveals Functionally Distinct Regions that Cooperate to Drive Tumorigenesis.	EPC2 SUPT20H ZDBF2 YEATS2 SUGP2 NXF1	4.78e-04	339	101	6	30415952
Pubmed	Comprehensive Interactome Mapping of the DNA Repair Scaffold SLX4 Using Proximity Labeling and Affinity Purification.	KPNA5 SUPT20H PIAS1 YEATS2 BRCA2	4.88e-04	222	101	5	37071664
Pubmed	SUMOylation activates large tumour suppressor 1 to maintain the tissue homeostasis during Hippo signalling.	PIAS1 BRCA2	5.41e-04	12	101	2	34267330
Pubmed	TNF-α inhibits glucocorticoid receptor-induced gene expression by reshaping the GR nuclear cofactor profile.	SENP3 ZDBF2 PIAS1 MED15 RAD51AP2 YEATS2 USP6 SLFN11	5.56e-04	638	101	8	31182584
Pubmed	A High-Density Map for Navigating the Human Polycomb Complexome.	KPNA5 ZNF280C JARID2 YEATS2 MTUS1 AEBP2 TADA2A	6.17e-04	495	101	7	27705803
Pubmed	MARK3-mediated phosphorylation of ARHGEF2 couples microtubules to the actin cytoskeleton to establish cell polarity.	TBC1D4 MTUS1 CEP170B	6.21e-04	57	101	3	29089450
Pubmed	The ATAC acetyl transferase complex controls mitotic progression by targeting non-histone substrates.	YEATS2 TADA2A	6.38e-04	13	101	2	20562830
Pubmed	Progesterone induced Warburg effect in HEK293 cells is associated with post-translational modifications and proteasomal degradation of progesterone receptor membrane component 1.	ATR SENP3 STYXL2	6.53e-04	58	101	3	31067491
Pubmed	MicroRNA-494, upregulated by tumor necrosis factor-α, desensitizes insulin effect in C2C12 muscle cells.	TBC1D4 NFKB1	7.43e-04	14	101	2	24349514
Pubmed	Sequential Activation of Two Pathogen-Sensing Pathways Required for Type I Interferon Expression and Resistance to an Acute DNA Virus Infection.	ZBP1 NFKB1	7.43e-04	14	101	2	26682986
Pubmed	An efficient method for generation of bi-allelic null mutant mouse embryonic stem cells and its application for investigating epigenetic modifiers.	EPC2 JARID2	7.43e-04	14	101	2	28981838
Pubmed	Identification of novel inhibitors of human immunodeficiency virus type 1 replication by in silico screening targeting cyclin T1/Tat interaction.	POLR2I POLR2M	7.43e-04	14	101	2	23274668
Pubmed	Control of HIV latency by epigenetic and non-epigenetic mechanisms.	POLR2I NFKB1	7.43e-04	14	101	2	22211660
Pubmed	Pot1a prevents telomere dysfunction and ATM-dependent neuronal loss.	ATR BRCA2	7.43e-04	14	101	2	24899707
Pubmed	The intracellular NADH level regulates atrophic nonunion pathogenesis through the CtBP2-p300-Runx2 transcriptional complex.	ATR NFKB1 SLFN11 SECTM1	8.43e-04	144	101	4	30585266
Pubmed	The Fanconi anemia family of genes and its correlation with breast cancer susceptibility and breast cancer features.	ATR FANCB	8.55e-04	15	101	2	19536649
Pubmed	Comparative mapping of two adjacent regions of MMU19 with their human counterpart on HSA11q13.	GRK2 PC	8.55e-04	15	101	2	9730611
Pubmed	The human immunodeficiency virus type 1 Vpr transactivator: cooperation with promoter-bound activator domains and binding to TFIIB.	POLR2I POLR2M	8.55e-04	15	101	2	8800208
Pubmed	TRIM28 functions as the SUMO E3 ligase for PCNA in prevention of transcription induced DNA breaks.	POLR2I PIAS1	8.55e-04	15	101	2	32900933
Pubmed	Cooperative interaction between HIV-1 regulatory proteins Tat and Vpr modulates transcription of the viral genome.	POLR2I POLR2M	8.55e-04	15	101	2	10931842
Pubmed	The HIV-1 Vpr co-activator induces a conformational change in TFIIB.	POLR2I POLR2M	8.55e-04	15	101	2	10359081
Pubmed	HIV-1 reverse transcription.	POLR2I POLR2M	8.55e-04	15	101	2	23028129
Pubmed	Estrogen-regulated feedback loop limits the efficacy of estrogen receptor-targeted breast cancer therapy.	TRPC6 LRRK2 SAMD7 NLRP9 SUGP2 SLC22A2 AEBP2 HYDIN	8.89e-04	686	101	8	29987050
Pubmed	Human transcription factor protein interaction networks.	RPL26 EPC2 SUPT20H PATL1 PIAS1 MED15 YEATS2 SUGP2 RPL26L1 NFKB1 TADA2A NXF1	9.03e-04	1429	101	12	35140242
Pubmed	Reciprocal requirements for EDA/EDAR/NF-kappaB and Wnt/beta-catenin signaling pathways in hair follicle induction.	WNT7B NFKB1	9.76e-04	16	101	2	19619491
Pubmed	The HIV-1 virion-associated protein vpr is a coactivator of the human glucocorticoid receptor.	POLR2I POLR2M	9.76e-04	16	101	2	9874563
Pubmed	Structure-function relationship of Vpr: biological implications.	ATR NFKB1	9.76e-04	16	101	2	19275588
Cytoband	17p13	RPL26 SENP3 ITGAE USP6	9.73e-07	34	101	4	17p13
Cytoband	9q31.1	OR13C5 OR13D1 OR13C9 OR13C2	2.10e-06	41	101	4	9q31.1
Cytoband	Ensembl 112 genes in cytogenetic band chr9q31	OR13C5 OR13D1 OR13C9 OR13C2	2.48e-04	137	101	4	chr9q31
Cytoband	9p13.3	OR2S2 ANKRD18B OR13C7	6.22e-04	75	101	3	9p13.3
GeneFamily	Olfactory receptors, family 13	OR13C5 OR13D1 OR13C9 OR13C2 OR13C7	2.07e-08	23	68	5	162
GeneFamily	ATAC complex	YEATS2 TADA2A	1.06e-03	13	68	2	1058
Coexpression	GSE6259_33D1_POS_DC_VS_CD4_TCELL_UP	UBTFL1 LRRK2 POLR2M ZDBF2 ITGAE ITPR1 UTRN	6.05e-06	184	98	7	M6756
Coexpression	GSE41867_NAIVE_VS_DAY6_LCMV_EFFECTOR_CD8_TCELL_DN	SUPT20H LRRK2 PIAS1 MED15 TGFBRAP1 NXF1 IL7R	1.04e-05	200	98	7	M9463
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_DN	SUPT20H ATR ITPR1 TDRD7 JARID2 USP6 PTPN2 SEC24D BRCA2 NFKB1 FAM169A AQR IL7R	1.82e-05	856	98	13	M4500
ToppCell	saliva-Severe-critical_progression_d28-40-Myeloid-Granulocytic-Neutrophil-Neu_c4-RSAD2\|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k)	TRPC6 BBS1 TDRD7 ZBP1 SEC24D UTRN SECTM1	1.51e-07	175	101	7	97616bb5c127284aa9e67bc336dfcf29e137164b
ToppCell	-Unknown-Endothelial-Myofibroblast\| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	LRRK2 ZDBF2 TDRD7 MTUS1 AEBP2 IL7R	4.48e-06	188	101	6	6468fa95ad0395395301115286f2d8c0df5d3882
ToppCell	-Unknown-Endothelial\| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	LRRK2 ZDBF2 TDRD7 MTUS1 AEBP2 IL7R	4.48e-06	188	101	6	7a81ac5c79c3eb26639b52d2b9fd5e7ef9798fd6
ToppCell	T_cells-ISG-high_CD4+_T_cells\|World / Immune cells in Kidney/Urine in Lupus Nephritis	TDRD7 ZBP1 YEATS2 TRANK1 TBC1D4 IL7R	4.48e-06	188	101	6	6f8946d4710f6e32c937213f99b790b098b8819c
ToppCell	-Unknown\| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	LRRK2 ZDBF2 TDRD7 MTUS1 AEBP2 IL7R	4.48e-06	188	101	6	9cb718bfe1358c6fd842f096e228eb0abb9aefc6
ToppCell	Control-CD8+_T_naive\|Control / Disease condition and Cell class	RASGRF2 CARS1 LRRN3 TBC1D4 MTUS1 IL7R	5.21e-06	193	101	6	627d345baf1940218c61907305705298e473dbab
ToppCell	PBMC-Control-Lymphocyte-T/NK-CD8+_T-CD8+_T_naive\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	RASGRF2 CARS1 LRRN3 TBC1D4 MTUS1 IL7R	5.21e-06	193	101	6	d371403b51281a6e37652fa8dc1b2dd81d2ab371
ToppCell	PBMC-Control-Lymphocyte-T/NK-CD8+_T-CD8+_T_naive-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	RASGRF2 CARS1 LRRN3 TBC1D4 MTUS1 IL7R	5.21e-06	193	101	6	6436d3bfce02d137b76e5c4c8b2fe27974c57c99
ToppCell	PBMC-Control-Lymphocyte-T/NK-CD8+_T-CD8+_T_naive-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	RASGRF2 CARS1 LRRN3 TBC1D4 MTUS1 IL7R	5.21e-06	193	101	6	3cde93bbfc1ae6fb586ae6b7aaa6ed8b5eee28a4
ToppCell	PBMC-Control-Lymphocyte-T/NK-CD8+_T-CD8+_T_naive\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	RASGRF2 CARS1 LRRN3 TBC1D4 MTUS1 IL7R	5.21e-06	193	101	6	d755dc6de4fbd4d8f5d8a88aac497e7b9e8b89de
ToppCell	BAL-Mild\|BAL / Location, Disease Group, Cell group, Cell class (2021.03.09)	RPL26 PARP8 ZBP1 TRANK1 TBC1D4 RPL26L1	5.69e-06	196	101	6	6566e6671257f7df4d3f375e84f0b292ab4bcde1
ToppCell	BAL-Mild\|BAL / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	RPL26 PARP8 ZBP1 TRANK1 TBC1D4 RPL26L1	5.69e-06	196	101	6	3408d561d29802fca9eff5c54ccf70818d240cea
ToppCell	mild-MAIT\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	RASGRF2 PARP8 ZDBF2 AEBP2 UTRN IL7R	6.21e-06	199	101	6	cbe1fb6d2c5fca7a1baf1ad20afcdf8e8e11bd84
ToppCell	COVID-19-COVID-19_Mild-Lymphocyte-T/NK-CD4+_T_activated\|COVID-19_Mild / Disease, condition lineage and cell class	RASGRF2 ANKRD18B LRRN3 TRANK1 TBC1D4 IL7R	6.39e-06	200	101	6	d9e8a0d047d4403fb7265fde7448e23a7780785c
ToppCell	Control-Control-Lymphocyte-T/NK-CD8+_T_naive\|Control / Disease, condition lineage and cell class	RASGRF2 CARS1 LRRN3 TBC1D4 MTUS1 IL7R	6.39e-06	200	101	6	906de95adc9716982ab32f216dddeb52639bad06
ToppCell	facs-Lung-Endomucin-24m-Endothelial-Capillary_Type_1_Cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CYP1A2 SAMD7 CNGB3 C2CD6 HYDIN	2.00e-05	145	101	5	96712c68ab759d7ade0d912581a1a7c25dc6def8
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c01-LEF1\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	SUPT20H PARP8 ZDBF2 LRRN3 IL7R	2.51e-05	152	101	5	aa88084ba1851d879ece82baa516f6b46cbd2eb8
ToppCell	severe_influenza-CD4+_T_naive\|World / disease group, cell group and cell class (v2)	LRRN3 NLRP9 TBC1D4 MTUS1 IL7R	3.03e-05	158	101	5	8ab3d8a9b7a1daa890d76dde1d6182af40b70021
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c01-LEF1\|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k)	SAMD7 TRANK1 TBC1D4 FAM13A IL7R	3.12e-05	159	101	5	b9d34b9ed8db798f5ea93c44b469cae499403cb8
ToppCell	Severe-Lymphoid-NK-innate_T\|Severe / Condition, Lineage, Cell class and cell subclass	RASGRF2 PARP8 ARHGEF25 FAM169A IL7R	3.83e-05	166	101	5	ee5ee75131fc0e22da0ceba3917f2104516af4b7
ToppCell	saliva-Severe-critical_progression_d12-22_no-steroids-Myeloid-Granulocytic-Neutrophil-Neu_c5-GSTP1(high)OASL(low)\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	LRRK2 ZBP1 TRANK1 UTRN SECTM1	4.29e-05	170	101	5	07b561cd9c528bc8444c9385e1de621eee7b697e
ToppCell	LPS-IL1RA+antiTNF\|World / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	LRRK2 TBC1D4 FAM13A MTUS1 UTRN	5.20e-05	177	101	5	b7fee75de7e96924af488a5baa2334711889ae7c
ToppCell	facs-Lung-nan-3m-Epithelial-club_cell_of_bronchiole\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	WNT7B SLC26A9 FAM13A MTUS1 PC	5.20e-05	177	101	5	e5070934c674a46e070b0d52b9a374516bf6aea1
ToppCell	facs-Lung-nan-3m-Epithelial-Club_Cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	WNT7B SLC26A9 FAM13A MTUS1 PC	5.20e-05	177	101	5	b37d821f4f3204daf7c568ac17a0af0ba97273d6
ToppCell	facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MED15 RAD51AP2 SEC24D CNGB3 PC	5.34e-05	178	101	5	fcbbcc44271515de1969b4732b6441c012693d5f
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c02-GPR183\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	RASGRF2 PARP8 LRRN3 MTUS1 IL7R	5.34e-05	178	101	5	31c847d7f7aa0f6d820afbb45d507992f5e9dc2f
ToppCell	T_cells-ISG-high_CD4+_T_cells\|T_cells / Immune cells in Kidney/Urine in Lupus Nephritis	TDRD7 YEATS2 TRANK1 BRCA2 SECTM1	5.48e-05	179	101	5	af35ef8a7768cee0c2af0590e5bec35cee6a4714
ToppCell	droplet-Marrow-nan-3m-Lymphocytic\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ITPR1 LRP8 SEC24D TBC1D4 IL7R	5.48e-05	179	101	5	dcaf2191134a586d50ebaf67dcf5b815b54a722b
ToppCell	LPS_only-Epithelial_alveolar-AT_2-Differentiating_AT2\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	LRRK2 RAD51AP2 SEC24D FAM13A MTUS1	5.48e-05	179	101	5	fd2cbee532e7b44113410dca82aec7db1a7fb69f
ToppCell	droplet-Marrow-nan-3m-Lymphocytic-nan\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ITPR1 LRP8 SEC24D TBC1D4 IL7R	5.48e-05	179	101	5	87a69f9f83b8f0c028a4874acb238f2e079bf51f
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	WNT7B LRRK2 TBC1D4 UTRN HYDIN	5.78e-05	181	101	5	071f9bb5d39070cdc473d9b0e094d196bc702b56
ToppCell	Leuk-UTI-Lymphocyte-T_NK-CD8_Naive\|Leuk-UTI / Disease, Lineage and Cell Type	CARS1 LRRN3 MTUS1 C2CD6 IL7R	5.93e-05	182	101	5	3500a826d86beb98980e2b24e074b02e8e2f957e
ToppCell	COVID-19_Mild-Lymphoid_T/NK-CD4+_T_activated\|COVID-19_Mild / Disease group, lineage and cell class	RASGRF2 LRRN3 TRANK1 TBC1D4 IL7R	6.09e-05	183	101	5	7717fce227b4e02ed41baad8ae7dd2e22bd7c13e
ToppCell	10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8\|GI_small-bowel / Manually curated celltypes from each tissue	ITPR1 FAM13A AP1G1 NFKB1 UTRN	6.91e-05	188	101	5	ab9b725d6e0cdab8e9ddda6dee09e14730e9a578
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD8_c01-LEF1\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	RASGRF2 PARP8 LRRN3 TBC1D4 IL7R	7.09e-05	189	101	5	e9df7ecd36bee1fedce23bb188c68a94fa60462c
ToppCell	10x5'-Lung-Myeloid_Monocytic-Nonclassical_monocytes\|Lung / Manually curated celltypes from each tissue	GRK2 SORCS2 UTRN CCDC26 SECTM1	7.45e-05	191	101	5	a862a571625ab7238589ff201e5954f602c3bd7e
ToppCell	PBMC-Mild-Lymphocyte-T/NK-CD8+_T-CD8+_T_naive-\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	RASGRF2 CARS1 LRRN3 TBC1D4 IL7R	7.64e-05	192	101	5	ad2e0f35d50fe4e6977eba8a7a2bd990f6946305
ToppCell	PBMC-Mild-Lymphocyte-T/NK-CD8+_T-CD8+_T_naive\|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09)	RASGRF2 CARS1 LRRN3 TBC1D4 IL7R	7.64e-05	192	101	5	284955fec5103194d416320f41fa4d87c7efc4fb
ToppCell	PBMC-Mild-Lymphocyte-T/NK-CD8+_T-CD8+_T_naive\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	RASGRF2 CARS1 LRRN3 TBC1D4 IL7R	7.64e-05	192	101	5	0d3b2b9cd586a4adbc3755563dd50b140227c287
ToppCell	PBMC-Mild-Lymphocyte-T/NK-CD8+_T-CD8+_T_naive-\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	RASGRF2 CARS1 LRRN3 TBC1D4 IL7R	7.64e-05	192	101	5	67f50e5b1d449923002dc5b5d0c4d32c523034d3
ToppCell	systemic_lupus_erythematosus-managed-Lymphocytic_T-T4_naive\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	RPL26 LRRN3 TBC1D4 FAM13A IL7R	8.41e-05	196	101	5	afafd3de2bc3a62d5dcd33801d7ec8f3f98fb7d2
ToppCell	COVID-19_Moderate-CD4+_T_naive\|COVID-19_Moderate / disease group, cell group and cell class	RPL26 LRRN3 TBC1D4 FAM13A IL7R	8.41e-05	196	101	5	b1a463cf4cf3755086f3420b8892d493af8cacbe
ToppCell	Mild-CD8+_T_activated\|World / Disease group and Cell class	KPNA5 PARP8 ZBP1 TRANK1 UTRN	8.41e-05	196	101	5	79632190e44fcef9d7c11d9b9e37f2ebf0e6e255
ToppCell	(2)_NK/T-(22)_CD8+_T_cell-(221)_CD8+_Naive_T_cell\|(22)_CD8+_T_cell / immune cells in Peripheral Blood (logTPM normalization)	RPL26 CARS1 LRRN3 TBC1D4 IL7R	8.62e-05	197	101	5	ac77bcd7548db40147bf55dbf0ce86ed0b6a86da
ToppCell	LPS_only-Epithelial_alveolar-AT_2\|LPS_only / Treatment groups by lineage, cell group, cell type	LRRK2 SEC24D FAM13A MTUS1 PLXNB1	8.83e-05	198	101	5	d087e738d69ca9853553fde46d4e7a8906439d32
ToppCell	LPS_IL1RA-Epithelial_alveolar-AT_2-Differentiating_AT2\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	LRRK2 SEC24D FAM13A MTUS1 PLXNB1	8.83e-05	198	101	5	285f729140b1df029c24f6ca1d2438470ac51794
ToppCell	Bronchial-NucSeq-Epithelial-Epi_alveolar-AT2\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	LRRK2 SLC26A9 TBC1D4 MTUS1 SORCS2	8.83e-05	198	101	5	f948391296c261c473d339069a6d0f20ccd6f38f
ToppCell	Parenchymal-NucSeq-Epithelial-Epi_alveolar-AT2\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	LRRK2 SLC26A9 TBC1D4 MTUS1 SORCS2	8.83e-05	198	101	5	2e2a4e1756bba6f4fbe529559a97d2993c890b4b
ToppCell	Control-Control-Lymphocyte-T/NK-CD4+_T_activated\|Control / Disease, condition lineage and cell class	EPC2 RASGRF2 LRRN3 TRANK1 IL7R	8.83e-05	198	101	5	ee71543559836fd59adc0da877b2ca538cba60cb
ToppCell	LPS_IL1RA_TNF-Epithelial_alveolar-AT_2-Differentiating_AT2\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	LRRK2 SEC24D FAM13A MTUS1 PLXNB1	9.25e-05	200	101	5	e8db082aa4d0597500e4f16a5c0ea3e62c6c59ae
ToppCell	COVID-19-COVID-19_Mild-Lymphocyte-T/NK-CD8+_T_naive\|COVID-19_Mild / Disease, condition lineage and cell class	RASGRF2 CARS1 LRRN3 TBC1D4 IL7R	9.25e-05	200	101	5	7192138e2704c030d70561bcd59259fb3ad82f06
ToppCell	Sepsis-ICU-SEP-Lymphocyte-T/NK-CD4+_T_naive\|ICU-SEP / Disease, condition lineage and cell class	RPL26 TULP3 LRRN3 FAM13A IL7R	9.25e-05	200	101	5	134a5e0cc46264b0aef69d4fd59f38fc7c334f69
ToppCell	mild-CD8+_T_naive\|mild / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	RASGRF2 CARS1 LRRN3 MTUS1 IL7R	9.25e-05	200	101	5	c2513047ef110a64c89a624e299cb9600a9cb92c
ToppCell	VE\|World / Condition, Cell_class and T cell subcluster	PARP8 TRANK1 GRK2 UTRN IL7R	9.25e-05	200	101	5	8ae7cb81de3ffac5acdf3466d4b516d80cac95d3
ToppCell	COVID-19-COVID-19_Severe-Lymphocyte-T/NK-CD4+_T_activated\|COVID-19_Severe / Disease, condition lineage and cell class	RASGRF2 LRRN3 TRANK1 TBC1D4 IL7R	9.25e-05	200	101	5	deeed668b129e66156b5f6abe1a07a9bf842a14d
ToppCell	\|World / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ODAD4 ZDBF2 C2CD6 ELMOD1	1.66e-04	121	101	4	da8fe561dcf50792d0cbcaad383d564f900a6677
Disease	Abnormality of radial ray	RPL26 FANCB BRCA2	1.64e-04	33	95	3	C4228778
Disease	infertility (implicated_via_orthology)	GCM2 BRCA2	2.13e-04	7	95	2	DOID:5223 (implicated_via_orthology)
Disease	blindness (implicated_via_orthology)	RPL26 RPL26L1	2.84e-04	8	95	2	DOID:1432 (implicated_via_orthology)
Disease	theophylline measurement	CYP1A2 LRRK2	4.54e-04	10	95	2	EFO_0021180
Disease	coffee consumption measurement, insomnia	SUPT20H PC	4.54e-04	10	95	2	EFO_0004698, EFO_0006781
Disease	Fanconi anemia	FANCB BRCA2	9.10e-04	14	95	2	cv:C0015625
Disease	quinate measurement	LRRK2 OR13D1	1.05e-03	15	95	2	EFO_0021167
Disease	lateral occipital cortex volume measurement	UTRN CCDC26	1.35e-03	17	95	2	EFO_0010311
Disease	sphingosine 1-phosphate measurement	ITPR1 SORCS2	1.52e-03	18	95	2	EFO_0800185
Disease	Bone marrow hypocellularity	FANCB BRCA2	1.52e-03	18	95	2	C1855710
Disease	Manic Disorder	FSTL5 TRANK1 PC	1.58e-03	71	95	3	C0024713
Disease	Manic	FSTL5 TRANK1 PC	2.07e-03	78	95	3	C0338831
Disease	Depression, Bipolar	FSTL5 TRANK1 PC	2.14e-03	79	95	3	C0005587
Disease	lung adenocarcinoma	CYP1A2 TRPC6 MTUS1 CCDC26	2.45e-03	174	95	4	EFO_0000571
Disease	Glioma	ATR BRCA2 CCDC26	2.82e-03	87	95	3	C0017638
Disease	pallidum volume change measurement, age at assessment	SORCS2 ELMOD1	2.93e-03	25	95	2	EFO_0008007, EFO_0021494
Disease	Fanconi Anemia	FANCB BRCA2	2.93e-03	25	95	2	C0015625
Disease	breast cancer (implicated_via_orthology)	ATR BRCA2	2.93e-03	25	95	2	DOID:1612 (implicated_via_orthology)
Disease	Pancytopenia	FANCB BRCA2	3.17e-03	26	95	2	C0030312

Protein segments in the cluster

Peptide	Gene	Start	Entry
NRLNRKMEIKPLQFE	EPC2	126	Q52LR7
NIYRTMPQKRLKRTL	AEBP2	491	Q6ZN18
FRKRIIKQLQNPDMA	ELMOD1	306	Q8N336
DLLIKPVQRIMKYQL	ARHGEF25	286	Q86VW2
PVQRIMKYQLLLKDF	ARHGEF25	291	Q86VW2
KMVKYLLDNRADPNI	ANKRD34C	66	P0C6C1
IELNRKYIPKMAIRI	ANKRD18B	966	A2A2Z9
IMRRKPKENNFKAVL	AQR	656	O60306
MRIPDQKYVTLKLND	CEP170B	71	Q9Y4F5
YREAQQLVQRVPKMK	GRK2	651	P25098
SYKNKALNPQEMRRR	KPNA5	16	O15131
RKARIKQLHPYLKQM	RAD51AP2	1136	Q09MP3
LYRKSAEKPQQELVM	NPFFR2	496	Q9Y5X5
MYLVTKPEIQRKIQK	CYP1A2	331	P05177
DINIKQVLLNMRKYR	PTPN2	241	P17706
NPQKQQLRMRIKLTY	AP1G1	786	O43747
LRKDPYANLMLQREK	PATL1	396	Q86TB9
MLNPIIYSLRNKDVK	OR13C7	291	P0DN81
MLNPLIYSLRNKEVK	OR5B21	281	A6NL26
NPRKKNYDRVMKALD	PARP8	596	Q8N3A8
ILKEDMLKIVNPRYQ	MAGEB5	61	Q9BZ81
LNKYIRKEPITREAM	MAGEB17	121	A8MXT2
LYNMRPKELVEVIKK	ITPR1	2121	Q14643
RAREKANLKNPQIMY	MTUS1	1121	Q9ULD2
KRLEKLRHQLMPMYN	C3orf18	86	Q9UK00
QQPRERLEKMKKEYR	C2CD6	321	Q53TS8
KYPLEQNQMILENKR	FSIP2	2446	Q5CZC0
LLRMQDKKINYIPEE	FSIP2	3381	Q5CZC0
ALNYPRNLQLKRMQK	ITGAE	871	P38570
QYVAKNPKLMLRRTE	PLXNB1	1666	O43157
PEQVEQLKLIMSKRY	NXF1	206	Q9UBU9
KYIEPLRRMINKIDK	MED15	541	Q96RN5
FLQQRLKKAVPYNRM	LRRK2	1321	Q5S007
LQRKLQPAAMYEIKV	IL7R	191	P16871
MNPLIYSLRNKDVKE	OR13C5	291	Q8NGS8
MLNPIIYSLRNKDVK	OR2S2	291	Q9NQN1
MNPLIYSLRNKDVKE	OR13C2	291	Q8NGS9
RPVTKNERQVMKPLY	FAM13A	821	O94988
NPEDVVRRYMQKVKN	DTX1	391	Q86Y01
KSYQPLMRLRHKQEK	FSTL5	31	Q8N475
PQKYRRKLVSQEEME	MRPS36	81	P82909
PYRKELQREKKKMLQ	FANCB	811	Q8NB91
MLNPIIYSLRNKDVK	OR5T1	296	Q8NG75
PINKYQRLVVKMKEE	CCDC26	56	Q8TAB7
SYPMRVNRCKEILNK	ATR	2186	Q13535
KHMPKYLRQKLRAEL	HYDIN	1746	Q4G0P3
NRMTLKQLKDRYPRK	GTPBP10	51	A4D1E9
QDMRIKKKQRQRVFP	BRCA2	2491	P51587
IKYNLRLNLKMFPVI	HYAL4	61	Q2M3T9
QKQRSLYLKKSRMEP	DUXB	151	A0A1W2PPF3
QLPVLDTMFLRKKYR	FAM169A	176	Q9Y6X4
EQERKNPMALYILKD	HEPACAM	301	Q14CZ8
IPQHMIQKTRKRKYF	CLK4	396	Q9HAZ1
KLAERLNIKMRSYNP	POLR2M	331	P0CAP2
QAMKLNVPRKTRLYV	BBS1	421	Q8NFJ9
NPLQKDPQYRRKVML	PPP1R7	331	Q15435
NMQRPRKNKEKMIYL	SLC22A2	531	O15244
MLPYSKENKQQVERK	GARNL3	281	Q5VVW2
DLVKRNYSRLIPMLK	LRP8	436	Q14114
MSKERPKRNIIQKKY	JARID2	1	Q92833
KELRQKYNVRSMPIR	RPL26L1	36	Q9UNX3
MNPLIYSLRNKDVKE	OR13C9	291	Q8NGT0
MLNPIIYSLRNKEVK	OR13D1	316	Q8NGV5
PEQLKLMRTQDVKYI	UTP11	91	Q9Y3A2
QPRLKGESKQVMKYR	UTRN	2076	P46939
NLYMAARKAVRKRPN	CARS1	526	P49589
INLRKFQLMERRYPK	TADA2A	231	O75478
YQQRRMEKINPKGLA	SAMD7	106	Q7Z3H4
QKYLKKQEKRRMRPT	SLC26A9	566	Q7LBE3
IRIKDMNFKPLINLR	LRRN3	201	Q9H3W5
EIIALNKTKERMRPY	RASGRF2	181	O14827
PVAYKKREMVVNLQK	TAF1B	441	Q53T94
QQKPIYARERDRKLM	ODAD4	241	Q96NG3
KRQMASFYQPQKKRI	GCM2	176	O75603
RRNEFVLMKLPKYAL	SORCS2	371	Q96PQ0
NNMLYPKEDKENRIL	POLR2I	21	P36954
PIAKYLQKEMQVIRS	SLFN11	736	Q7Z7L1
PAQYLKLRERMQIQK	SKIV2L	1021	Q15477
NIRKVQPLVDMFRKL	TDRD7	1001	Q8NHU6
KIKELYRRRFPQKIM	PIAS1	56	O75925
RPYSMKLTIVKQREQ	SEC24D	981	O94855
MNNYSIPKLVQKRVR	CNGB3	466	Q9NQW8
TKAQEEMRNKLNPYR	NLRP9	86	Q7RTR0
FTQQDMPKLRRQIYK	SENP3	551	Q9H4L4
FLRIKQLRSYQKPME	WNT7B	251	P56706
ARRNIPKEKFQVMYR	TGFBRAP1	336	Q8WUH2
PKEKFQVMYRRILQQ	TGFBRAP1	341	Q8WUH2
YKRMLNKRPTLKDLE	WWP2	631	O00308
LPEQMKQKYIQDFRK	UBTFL1	141	P0CB47
PKRELNQVLYRMKKE	ZBP1	41	Q9H171
QRREKKFFLLEPQMK	SECTM1	176	Q8WVN6
KELRQKYNVRSMPIR	RPL26	36	P61254
ALMTVRKKRAIYPNE	STYXL2	251	Q5VZP5
RLLYNKQKMNTRPMK	SUPT20H	221	Q8NEM7
IIKPFDKYIMRLQDR	SUGP2	421	Q8IX01
KNYPVMKRKIIRQEE	ZDBF2	1951	Q9HCK1
MAYQKTVEQLRKLLP	TBC1D4	1256	O60343
PSYKQKRQRNRKNKM	ZNF280C	591	Q8ND82
PPRQYQKIMKRLIKR	TRPC6	851	Q9Y210
NMKIQKRIPRCYVED	TRANK1	941	O15050
QLMDLYQLKSPRIQK	WDR87	2756	Q6ZQQ6
RLEYKPIKKVMVANR	PC	31	P11498
EKRQRKKRLEPFMVQ	TULP3	36	O75386
IQEIKLKNPGRYQIM	USP6	116	P35125
MRKVLQEILEKNPRF	YEATS2	1201	Q9ULM3
KEEVQRKRQKLMPNF	NFKB1	356	P19838